|
Return to Contents in this
Issue |
|
Case Report |
|
|
|
Acute Generalized Exanthematous
Pustulosis Due to Tetrazepam |
|
|
|
E Thomas,1 T Bellón,2
P Barranco,1 A Padial,1 B Tapia,2
E Morel,2 J Alves-Ferreira,3 M
Martín-Esteban1 |
|
1Allergy Department, Hospital La Paz,
Madrid, Spain
2Research Unit, Hospital La Paz, Madrid, Spain
3Pathology Department, Hospital La Paz, Madrid, Spain |
|
J Investig Allergol Clin Immunol
2008; Vol. 18(2): 119-122 |
|
|
|
Abstract |
|
Tetrazepam is a
benzodiazepine that
is widely used in
Spain as a muscle
relaxant, with
occasional cutaneous
side effects. We
report a patient who
developed a
generalized
pruriginous
cutaneous reaction
compatible with
acute generalized
exanthematous
pustulosis (AGEP)
due to tetrazepam.
Patch tests with
bromazepam, diazepam,
and tetrazepam were
negative at 48 and
72 hours; however,
the tetrazepam patch
showed a positive
reaction at 10 days.
Immunohistochemical
studies revealed a
mononuclear infi
ltrate composed of
CD4+ and CD8+ T
lymphocytes.
Analysis of
interleukin (IL) 8
expression by
quantitative
polymerase chain
reaction revealed
increased IL-8 mRNA
levels in patch test-positive
skin. Lymphoblast
transformation test
(LTT) was positive
with tetrazepam but
not with diazepam.
Positive patch test
and LTT suggested
that tetrazepam-specifi
c lymphocytes might
be responsible for a
T cell-mediated
reaction. These
results support
previous data
suggesting an
important role for
IL-8 and drug-specific
T cells in the
pathogenesis of AGEP
and imply that the
reaction was specifi
c
to tetrazepam with
no cross-reactivity
to other
benzodiazepines.
Key words:
Acute generalized
exanthematous
pustulosis.
Benzodiazepines.
Drug reaction.
Interleukin-8.
Lymphocyte
transformation test.
Patch test.
Tetrazepam. |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|